⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26622081 | 0.87 | — | — | |
| SCHEMBL1145474 | 0.83 | — | — | |
| SCHEMBL9644539 | 0.81 | — | — | |
| SCHEMBL2335019 | 0.81 | — | — | |
| SCHEMBL173320 | 0.81 | — | — | |
| SCHEMBL23174998 | 0.81 | — | — | |
| SCHEMBL2032189 | 0.80 | — | — | |
| SCHEMBL10953427 | 0.79 | CES2 (0.48) | — | |
| SCHEMBL9802054 | 0.79 | CES2 (0.48) | — | |
| SCHEMBL4954643 | 0.79 | CES2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117120476-A | Antibodies specific for structurally disordered sequences | XL-普洛坦公司 | 2023-11-24 | — | — | CN | claimed |
| EP-4267628-A1 | ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES | XL-protein GmbH (DE) | 2023-11-01 | — | — | EP | claimed |
| WO-2022136582-A1 | ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES | XL-PROTEIN GMBH (DE) | 2022-06-30 | — | — | WO | claimed |
| US-20200282071-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-PROTEIN GMBH (DE) | 2020-09-10 | — | — | US | claimed |
| EP-3641827-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-protein GmbH (DE) | 2020-04-29 | — | — | EP | claimed |
| CN-110891612-A | Conjugates of protein drugs and P/A peptides | XL-蛋白有限责任公司 | 2020-03-17 | — | — | CN | claimed |
| WO-2018234455-A1 | CONJUGATES OF PROTEIN DRUGS AND P/A PEPTIDES | XL-PROTEIN GMBH (DE) | 2018-12-27 | — | — | WO | claimed |
| US-20070078146-A1 | Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma | PHARMACIA CORPORATION | 2007-04-05 | — | — | US | claimed |
| EP-1144403-B1 | SUBSTITUTED PYRAZOLES AS P38 KINASE INHIBITORS | SEARLE LLC (US) | 2004-10-06 | — | — | EP | claimed |
| US-6617324-B1 | Phenyl, cyclohexyl and pyridinyl or pyrimidinyl-substituted | G. D. SEARLE & COMPANY | 2003-09-09 | — | — | US | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1144403-A1 | SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000031063-A1 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-06-02 | — | — | WO | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| US-4590209-A | INOTROPIC, ANTIARRHYTHMIA, AND ANTILIPEMIC AGENTS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1986-05-20 | — | — | US | claimed |
| US-4551477-A | ANTILIPEMIC AGENTS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 1985-11-05 | — | — | US | claimed |
| EP-0000931-B1 | ENZYMATIC CLEAVAGE OF N-ACYL-THIENAMYCINS | MERCK & CO. INC. (US) | 1982-04-14 | — | — | EP | claimed |
| US-4162193-A | Enzymatic cleavage of N-acyl-thienamycins | MERCK & CO., INC. (US) | 1979-07-24 | — | — | US | claimed |
| EP-0000931-A1 | Enzymatic cleavage of N-acyl-thienamycins | MERCK & CO. INC. (US) | 1979-03-07 | — | — | EP | claimed |